Nexalin Technology Inc Warrant
NXLIW
NXLIW was delisted on the 19th of September, 2025.
6 hedge funds and large institutions have $195K invested in Nexalin Technology Inc Warrant in 2025 Q1 according to their latest regulatory filings, with funds opening new positions, 1 increasing their positions, 3 reducing their positions, and 0 closing their positions.
0% more funds holding
Funds holding: 6 → 6 (0)
0.46% less ownership
Funds ownership: 7.76% → 7.3% (-0.46%)
49% less capital invested
Capital invested by funds: $384K → $195K (-$188K)
67% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 3
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
+$20.4K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
WAM
Warberg Asset Management
Winnetka,
Illinois
|
-$20K |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$7.51K |
| 3 |
CS
Clear Street
New York
|
-$64 |
NXLIW Hedge Fund Activity: Q1 2025 in Review
6 of the 7,459 institutional investors tracked by Wall St. Rank reported a position in Nexalin Technology Inc Warrant (NXLIW) for Q1 2025, worth a combined $195K — down 49% from $384K a quarter earlier.
Fund positioning in NXLIW was balanced in Q1 2025: 0 funds opened new positions, 0 closed out, 1 added to existing stakes and 3 trimmed.
The largest buyer was UBS Group, adding an estimated $20.4K. The largest seller was Warberg Asset Management, cutting an estimated $20K.
- 6 institutional investors held Nexalin Technology Inc Warrant (NXLIW) as of Q1 2025, unchanged from Q4 2024.
- Funds reported $195K of Nexalin Technology Inc Warrant stock for Q1 2025, down 49% quarter-over-quarter.
- 0 funds opened new Nexalin Technology Inc Warrant positions in Q1 2025 and 0 closed out.
- The largest Nexalin Technology Inc Warrant buyer in Q1 2025 was UBS Group, an estimated $20.4K added.
- The largest Nexalin Technology Inc Warrant seller in Q1 2025 was Warberg Asset Management, an estimated $20K sold.
Based on aggregated 13F filings for Q1 2025.